Loading...
Cathepsin B Polyclonal Antibody

42471

Cathepsin B Polyclonal Antibody

Cathepsin B Polyclonal Antibody (catalogue number 42471) is a rabbit-derived primary antibody validated for Immunohistochemistry, reactive with Human samples. It targets Cathepsin B (CTSB): Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Supplied as 100μg at ₪1,590.78; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human
Applications
Immunohistochemistry
UniProt ID
P07858
Gene
CTSB
Target organism
Homo sapiens
Catalogue number
42471
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Cathepsin B (CTSB) · Homo sapiens

Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Cleaves matrix extracellular phosphoglycoprotein MEPE. Involved in the solubilization of cross-linked TG/thyroglobulin in the thyroid follicle lumen. Has also been implicated in tumor invasion and metastasis

Subcellular location: Lysosome; Melanosome; Secreted, extracellular space; Apical cell membrane

Tissue specificity: Expressed in the stratum spinosum of the epidermis. Weak expression is detected in the stratum granulosum

Sequence length: 339 aa · 37822 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.